Feasiblity of Xpert Ebola assay in Medecins Sans Frontieres Ebola Program, Guinea

Rapid diagnostic methods are essential in control of Ebola outbreaks

Abstract

Diagnosis during Ebola outbreaks in West Africa has relied on PCR performed in laboratories outside this region. A total of 218 samples were collected during diagnosis, treatment, and convalescence of patients. The authors highlight several logistic and safety issues were identified. They suggest that implementation of the Xpert Ebola Assay under programmatic conditions is feasible and represents a major advance in diagnosis of Ebola virus disease without apparent loss of assay sensitivity.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Van den Bergh R, Chaillet P, Sow M, et al. Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea. Emerging Infectious Diseases. 2016;22(2):210-216. doi:10.3201/eid2202.151238

Feasiblity of Xpert Ebola assay in Medecins Sans Frontieres Ebola Program, Guinea

Updates to this page

Published 8 February 2016